PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute of Medical Immunology, Martin Luther University Halle-Wittenberg, Halle, Germany.\', \'Institute of Pathology, Martin Luther University Halle-Wittenberg, Halle, Germany.\', \'Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany.\', \'German Cancer Consortium (DKTK), Partner Site Dresden, and German Cancer Research Center (DKFZ), Heidelberg, Germany.\', \'National Center for Tumor Diseases, University Hospital \'Carl Gustav Carus,\' Technische Universität (TU) Dresden, Dresden, Germany.\', \'Tumor Immunology, University Cancer Center \'Carl Gustav Carus,\' Technische Universität (TU) Dresden, Dresden, Germany.\', \'Cell therapy and Immunology, Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.3389/fimmu.2021.597399
?:doi
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 33796097
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
is ?:relation_isRelatedTo_publication of
?:title
  • Immune Interaction Map of Human SARS-CoV-2 Target Genes: Implications for Therapeutic Avenues.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33796097>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33796097>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all